The primary purpose of PancreasFest is to bring physicians and investigators together to discuss well-designed multi-center studies to advance our understanding of the origin and progression of pancreatic diseases. Ultimately, we strive to provide optimal treatments to patients as soon as possible. PancreasFest emerged from the annual meeting of the Midwest Multicenter Pancreatic Study Group and the annual investigators meeting of the North American Pancreatic Study Group. This meeting is led by academic physicians who are committed to collaboration to support patients who desperately need answers.
This course is designed for gastroenterologists, surgeons, oncologists, radiologists, basic and clinical researchers and general physicians interested in pancreatic diseases. Physicians and scientists interested in translational research, cooperative studies and career development are encouraged to attend. Advanced providers, clinical and research nurses and related health care professionals interested in pancreatic disease research and treatments should also attend.
• Partner with other academic, clinical, and research pancreas groups to discussion collaborative, patient-centered care.
• Identify advancements in pancreas care, especially related to pancreatitis, pancreatic cancer, and exocrine pancreatic insufficiency advancements.
• Address pediatric pancreatitis care, especially related to drug trials for children and research collaborations.
• Foster the development of multidisciplinary, fluid, and interactive models to treat pancreas diseases.
PF21 Course Co-Directors:
Nathan Bahary, MD, PhD Steven J. Hughes, MD
Randall E. Brand, MD Aliye Uc, MD
Gregory A. Coté, MD, MS David C. Whitcomb, MD, PhD
Course Faculty Disclosures
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
▪ Nathan Bahary, MD, PhD is a consultant with AstraZeneca, Exelixis, and Bristol Myers Squibb.
▪ Jodie Barkin, MD is a consultant with Abbvie Inc., Nestle Health Sciences Inc., HealthiVibe Inc., and Envara Health Inc.
▪ Randall Brand, MD receives grant/research support from Freenome and Immunovia.
▪ Gregory Cote, MD, MS receives grant/research support from Kangen Pharmaceuticals. He is also a consultant with the Olympus Corporation and is on the CE speakers’ bureau for Abbvie.
▪ Toren Finkel, MD, PhD is a stockholder with Generian Pharmaceuticals.
▪ A. Jay Freeman, MD, MSc receives grant/research support from the NIH, CFF, Vertex Pharmaceuticals, and Travere Therapeutics. He is also a consultant with Abbvie.
▪ Anna Gloyn, DPhil is a stockholder with Genentech and holds stock options with Roche.
▪ Vivek Kaul, MD is a consultant with Cook Medical, Steris Corp, Ambu, and Microtech.
▪ Peter Lee, MBChB is on an Abbvie advisory board.
▪ Michael Lotze, MD is a consultant with iRepoertoire and Checkmate. He is also the Chief Cell Therapy Officer for Nurix Therapeutics.
▪ Mark Lowe, MD, PhD is a consultant with the CF Foundation. He also receives royalties from UptoDate and Sigma-Millipore.
▪ Georgios Papachristou, MD, PhD receives grant/research support from the NIDDK, DOD, and Abbvie. He is also a consultant with Nestle.
▪ Michael Rickels, MD, MS is a consultant with Semma Therapeutics and the Sernova Corporation.
▪ Vijay P. Singh, MD, MBBS is a consultant with Lamassu Pharma, LLC.
▪ Vikesh Singh, MD, MSc receives grant/research support from Orgenesis and Theraly, and he is a consultant for Abbvie and Nestle Health Science. He is also an advisory board participant for Envara.
▪ Virginia Stallings, MD receives grant/research support from the NIH, HHS, CF Foundation, Vertex, Abbvie, and Chiesi. She is a consultant for Abbvie, Abbott, Envara Health, and Nestle Nutrition Sciences. She is also a stockholder with Danone and Envara Health.
▪ Eva Szigethy, MD, PhD receives grant/research support from PCORI and the NIH, and she is associated with APPI.
▪ David Whitcomb, MD, PhD receives grant/research support from the NIH, Dept. of Defense, and the Wayne Fussaro Pancreatic Cancer Research Fund. He is a consultant with Abbott, Ariel Precision Medicine, BioNTech, Nestle, Novartis, Regeneron, and Samsung. He is also a stockholder with Ariel Precision Medicine.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The information presented at this CME program represents the views and opinions of the individual presenters and does not constitute the opinion of endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 12.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 12.00 Attendance
We acknowledge generous educational grant support for the PancreasFest 2021 conference from the following industry partners:
Boston Scientific Corporation
Cook Medical, LLC
Ipsen Biopharmaceuticals, Inc.
Olympus Corporation of the Americas
We acknowledge generous exhibit support for the PancreasFest 2021 conference from the following industry partners:
Tier I: PLATINUM Level
Boston Scientific Corporation
Tier II: GOLD Level
Nestlé Health Sciences
Tier III: SILVER Level
Ariel Precision Medicine, Inc.
Medtronic Gastrointestinal Hepatology
Olympus America, Inc.